Skip to content
Home/GPs/Qubis
Qubis

Qubis

Belfast, United Kingdom·Founded 1984··qubis.co.uk

QUBIS Ltd is the technology-transfer and spin-out investment company of Queen's University Belfast, wholly owned by the University and incorporated in 1984. From its Belfast base it takes direct equity stakes in university spin-outs across life sciences, digital, engineering, environmental and scientific technology, and has helped create more than 100 companies. Not FCA-authorised as an AIFM, it invests as a balance-sheet evergreen holder and reported net assets of GBP 165.1m in its 2024 accounts.

AUM
€193M
Funds
1
vintages 1984
Portfolio
43
Exits
10
SectorsHealthcareTMTSoftwareIndustrialsEnergy

Key facts

HQBelfast, United Kingdom
Founded1984
Employees7+

Recent exits

Titan IC Systems Ltd
Cybersecurity · 2020 · 12yr hold
Fusion Antibodies Plc
Biotech · 2017 · 15yr hold
PathXL Ltd
HealthTech · 2016 · 9yr hold
Trucorp Ltd
MedTech · 2016 · 14yr hold

Coverage notes

1 fund tracked, 53 portfolio companies (43 active · 10 realized). Verified weekly from public filings and deal announcements.

Funds & portfolio

Every fund Qubis has raised, with its portfolio companies. Hand-checked from public filings.

1 fund
QUBIS LtdEvergreen
1984 · 42yr€193M43 active · 10 realized

Unrealized

43 held
IndustrialsUK· Entry 1995
AI/MLUK· Entry 2013
HealthTechUK· Entry 2019
AilsebioActive
BiotechUK· Entry 2021
HealthTechUK· Entry 2004
BiotechUK· Entry 2021
Data & AnalyticsUK· Entry 2009
BiotechUK· Entry 2021
Data & AnalyticsUK· Entry 2019
BiotechUK· Entry 1993
BirotaActive
Business ServicesUK· Entry 2024
BiotechUK· Entry 2022
FintechUK· Entry 2023
ClimateTechUK· Entry 2013
HealthTechUK· Entry 2014
HealthTechUK· Entry 2012
BiotechUK· Entry 2019
BiotechUK· Entry 2022
IndustrialsUK· Entry 2005
SoftwareUK· Entry 2002
IndustrialsUK· Entry 2019
GeneratRActive
BiotechUK· Entry 2022
BiotechUK· Entry 2024
ClimateTechUK· Entry 2015
MedTechUK· Entry 2025
LoyalBeActive
FintechUK· Entry 2025
Business ServicesUK· Entry 1987
BiotechUK· Entry 2022
NuadaActive
ClimateTechUK· Entry 2013
ClimateTechUK· Entry 2019
HealthTechUK· Entry 2021
BiotechUK· Entry 2016
ReNewVaxActive
BiotechUK· Entry 2025
ReproGoActive
HealthTechUK· Entry 2020
RetinizeActive
SoftwareUK· Entry 2025
IndustrialsUK· Entry 2008
IndustrialsUK· Entry 2023
SignaCorActive
BiotechUK· Entry 2024
AI/MLUK· Entry 2018
BiotechUK· Entry 2025
IndustrialsUK· Entry 2011
BiotechUK· Entry 2019
BiotechUK· Entry 2019

Realized

10 exits
TMTUK· Entry 1990
Trade Saleto
Andor TechnologyExited 2004
IndustrialsUK· Entry 1990
IPO
IndustrialsUK· Entry 2001
Trade Saleto
BiotechUK· Entry 2002
IPO
Kainos Group PlcExited 2015
IT ServicesUK· Entry 1987
IPO
SoftwareUK· Entry 1996
Trade Saleto
Meridio LtdExited 2007
SoftwareUK· Entry 2001
Trade Saleto
PathXL LtdExited 2016
HealthTechUK· Entry 2007
Trade Saleto
CybersecurityUK· Entry 2008
Trade Saleto
Trucorp LtdExited 2016
MedTechUK· Entry 2002
Trade Saleto
Track Qubis

Saved GPs appear in your watchlist, one click from your workspace.

About Qubis

Qubis is a British private equity and investment platform with capital deployed across 2 active fund vehicles, headquartered in London. The firm operates across multiple alternative strategies, with capital deployed into European businesses across TMT, healthcare, software, industrials, business services and consumer.

Investment thesis

Qubis operates across complementary alternative investment strategies, deploying capital into European businesses across TMT, healthcare, software, industrials, business services and consumer. The multi-strategy platform enables diversified capital deployment across the business lifecycle from venture and growth equity to mid-cap buyouts, with capital sourced from institutional limited partners and selective family-office capital across the United Kingdom and broader European market.

Recent activity

Recent realised exits include Meridio Ltd (TMT, 2021) and Tactility Factory (TMT, 2017). The platform tracks 2 fund vehicles, 104 active portfolio companies and 2 realised exits across the strategy's history. Detailed buyer names and multiple data available on Pro at €29/month.

Last updated April 2026 · Sourced from public filings